Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-24 Sale |
2025-02-25 3:43 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer |
14,168 | $9.4534 | $133,936 | 117,901 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-02 8:58 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer |
2,711 | $10.05 | $27,251 | 132,081 (Indirect Direct) |
View |
| 2024-02-22 Sale |
2024-02-26 7:34 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer |
12,296 | $10.05 | $123,521 | 199,792 (Indirect Direct) |
View |
| 2023-03-30 Sale |
2023-03-31 2:40 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
2,627 | $22.77 | $59,817 | 114,588 (Indirect Direct) |
View |
| 2023-02-23 Sale |
2023-02-24 8:35 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
2,302 | $25.97 | $59,790 | 172,215 (Indirect Direct) |
View |
| 2022-03-30 Sale |
2022-03-31 2:46 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
2,627 | $26.24 | $68,925 | 81,485 (Indirect Direct) |
View |
| 2021-11-29 Purchase |
2021-12-01 8:20 pm |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
12 | $43.39 | $500 | 30,612 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-22 Option Award |
2024-02-26 7:34 pm |
N/A 2034-02-21 |
Vir Biotechnology Inc. | VIR | HANLY ANN M. EVP & Chief Technology Officer |
97,500 | $0 | 199,792 (Direct) |
View |
| 2023-02-22 Option Award |
2023-02-24 8:35 pm |
N/A 2033-02-21 |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
92,500 | $0 | 172,215 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 9:33 pm |
N/A 2032-02-21 |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
100,500 | $0 | 131,112 (Direct) |
View |
| 2021-03-29 Option Award |
2021-03-31 6:17 pm |
N/A 2031-03-28 |
Vir Biotechnology Inc. | VIR | HANLY ANN M. Chief Technology Officer |
90,000 | $0 | 90,000 (Direct) |
View |